At a Covid-19 testing centre in the UAE.
PHOTO BY DUBAI HEALTH AUTHORITY
DUBAI – The UAE is currently conducting clinical trials of a Covid-19 inactivated vaccine, and results from the final stages of the third phase revealed whether or not the vaccine is safe.
At a media briefing on Monday (September 14), Abdulrahman bin Mohammed Al Owais, the UAE’s Minister of Health and Prevention, said results confirmed that the vaccine is “safe and effective”.
Al Owais said the vaccine resulted in strong generation of Covid-19 antibodies among volunteers who took the vaccine trials.
“The studies related to the safety of vaccination are conducted under the strict supervision of medical teams. Health authorities are following procedures to control the quality, safety and efficacy of the vaccine,” he said.
The vaccine was tested with the help of 31,000 volunteers from 125 nationalities.
Al Owais said that volunteers displayed minor side effects, which were expected as a result of any vaccine. The side effects included headaches, fatigue and slight pain in the injection area.
UAE health authorities also confirmed that 1,000 volunteers with history of chronic illness haven’t experienced any complications after taking the vaccine.
The initial successful results of the vaccine mark the UAE’s positive steps in the vaccine development process.
On Monday, the UAE announced authorizing the emergency use of the Covid-19 vaccine for health workers on the frontlines of the battle against the pandemic. The vaccine is provided optionally to health workers in direct contact with Covid-19 patients.
The UAE’s vaccine trials are part of the extensive measures that the UAE has taken to contribute to the global collective efforts to curb Covid-19 pandemic that has posed the greatest public health emergency in modern history.
So far, the UAE has conducted more than million tests and recorded no new fatalities in the last 48 hours.
The vaccine was evaluated based on approval qualification criteria for emergency use, in accordance with the declaration of the global health authorities surrounding an emergency, the availability of scientific evidence on the effectiveness of the product and the benefits outweighing the risks.
The emergency use takes into account the target groups, product characteristics, clinical and pre-clinical study data and population study.
Health authorities are working closely in collaboration with the vaccine developers to monitor the progress of the vaccine and follow necessary safety measures to control the quality, safety and efficacy of the vaccine. ICA/Expat Media
Dubai: Upcoming iconic attractions, world record breakers
Qatar women strip search: Airport officials referred to prosecutors
Dubai to develop 12km beachfront worth Dh500 million
James Bond actor Sean Connery dies at 90
Filipino police officer killed in rooster attack during raid
Saudi national arrested for attacking French consulate guard in Jeddah
Germany hits Covid-19 record with 16,774 new cases in 24 hours
Covid-19 in UAE: 3 deaths, 1,312 new cases, 1,500 recoveries in 24 hours
OFWs charged up to P20,000 for swab test? Investigation launched
Single Covid-19 PCR test requirement to enter Dubai: List of countries announced